Most MM have potential mutations occurring mainly in components of the phosphoinositide kinase (PI3K/Akt) signaling pathways and mitogen-activated protein kinase (MAPK) [6, 13]. This evidence concerns the gene AKT1 and Miyoshi myopathy.